Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Nanion Technologies and Axion Biosystems Announce Strategic Distribution Partnership in Europe and China

Abstract:
Nanion Technologies, a leading provider of automated patch clamp platforms, and Axion Biosystems, originator of the first high throughput microelectrode array system, today announce a distribution partnership in Europe and China. Nanion will immediately carry Axion's MEA-products, supporting a broad range of biomedical applications.

Nanion Technologies and Axion Biosystems Announce Strategic Distribution Partnership in Europe and China

Munich, Germany | Posted on June 19th, 2014

Axion Biosystems provides state-of-the-art, high resolution, MEA based instruments for experiments ranging from basic cellular electrophysiology to high throughput screening (HTS). Axion's MEA systems represent the next generation in multielectrode array technology, providing unprecedented access to native cellular electrical signaling and connectivity. To meet the growing demand for "disease in a dish" assays and functional safety screening, Axion and Nanion today announced a strategic distribution partnership for the European and Chinese markets.

Further strengthening and complementing the Nanion product portfolio, Nanion will distribute, service, and support the Axion single-well MEA system, the Muse, and the Maestro, a multiwell MEA system with HTS capabilities.

Dr. Niels Fertig, CEO and founder of Nanion Technologies, says: "We are extremely impressed by Axion's MEA-systems because of their broad scope of applications, ranging from in-depth, highly resolved cellular network behavior to high throughput drug screening. We think that Axions's products provide an excellent complement to our automated patch clamp screening and impedance-based systems, and see great potential for applications including phenotype screening, stem cells as tools for phenotypic disease models, and of course, safety, neuro- and cardiotoxicity testing. Additionally, the partnership with Axion will further strengthen us as the one-stop-shop for proficient tools for electrophysiology drug research, screening and intersecting areas."

Tom O'Brien, CEO of Axion Biosystems, continues: "Nanion is a great match for Axion, since we share the same background and philosophy, ultimately manifested in innovative products. As companies, we both have a solid research- and application-driven focus, as well as a deep understanding and broad expertise in science and technical development. These characteristics are combined with a vision to push the boundaries toward HTS-compatible products. We were attracted to Nanion's strong track record of growth, and their excellent reputation for customer service and product reliability. We are excited about this partnership and have great confidence that Nanion will be very successful as our sales and distribution partner for the European and Chinese markets."

Nanion Technologies and Axion Biosystems will be displaying their products together at the MEA-meeting in Reutlingen, Germany, July 1-4, 2014, and at the FENS 2014 meeting in Milan, Italy, July 4-7, 2014.

####

About Nanion Technologies
Nanion Technologies GmbH is a German Private Limited Company and was founded in 2002 as a spin-off from the Center for Nanoscience (CeNS) of the University of Munich. Nanion's team has developed and globally established four generations of highly successful automated patch clamp instruments as enabling tools for sophisticated and high throughput applications for ion channel research and drug discovery. Nanion also carries the in-house developed product lines the CardioExcyte 96, for cardiac safety screening, and the SURFE2R N96, a device for parallel membrane transporter protein recordings.

In 2013, Nanion launched a high quality, fully HTS-compatible, automated patch clamp platform, the SyncroPatch 384/768PE, capable of over 20,000 data points per day.

About Axion Biosystems

Axion Biosystems is a life science company focused on solving problems related to human heart and brain activity. Axion tackles these problems by integrating its core technologies - proprietary electronics and microfabrication methods - with biology. This capability has led The Company to initiate the development of products for three different markets - life science instrumentation, medical diagnostics, and implantable stimulation devices.

For more information, please click here

Contacts:
Dr. Cecilia Farre
Press Contact
Tel: +49 (89) 218997973


Contact Axion Biosystems:
Jim Filippini
Director
Global Sales and Marketing
Phone 404-477-2557


Tom O'Brien
CEO
Phone 404-477-2557

Web: www.axionbio.com
Dr. Niels Fertig
CEO
Tel: +49 (89) 2189979-72

Copyright © Nanion Technologies

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Haydale Secures Exclusive Development and Supply Agreement with Tantec A/S: New reactors to be built and commissioned by Tantec A/S represent another step forward towards the commercialisation of graphene October 24th, 2014

QuantumWise guides the semiconductor industry towards the atomic scale October 24th, 2014

MEMS & Sensors Technology Showcase: Finalists Announced for MEMS Executive Congress US 2014 October 23rd, 2014

Nanoparticle technology triples the production of biogas October 23rd, 2014

Announcements

Haydale Secures Exclusive Development and Supply Agreement with Tantec A/S: New reactors to be built and commissioned by Tantec A/S represent another step forward towards the commercialisation of graphene October 24th, 2014

QuantumWise guides the semiconductor industry towards the atomic scale October 24th, 2014

Advancing thin film research with nanostructured AZO: Innovnano’s unique and cost-effective AZO sputtering targets for the production of transparent conducting oxides October 23rd, 2014

Strengthening thin-film bonds with ultrafast data collection October 23rd, 2014

Tools

Haydale Secures Exclusive Development and Supply Agreement with Tantec A/S: New reactors to be built and commissioned by Tantec A/S represent another step forward towards the commercialisation of graphene October 24th, 2014

National Synchrotron Light Source II Achieves 'First Light' October 23rd, 2014

Advancing thin film research with nanostructured AZO: Innovnano’s unique and cost-effective AZO sputtering targets for the production of transparent conducting oxides October 23rd, 2014

NIST offers electronics industry 2 ways to snoop on self-organizing molecules October 22nd, 2014

Alliances/Partnerships/Distributorships

European Commission opens the gate towards the implementation of Nanomedicine Translation Hub October 16th, 2014

IRLYNX and CEA-Leti to Streamline New CMOS-based Infrared Sensing Modules Dedicated to Human-activities Characterization October 15th, 2014

New VDMA Association "Electronics, Micro and Nano Technologies" founded: Inaugural Meeting in Frankfurt/Main, Germany October 15th, 2014

VDMA photonics steering committee with new members stronger than ever October 14th, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE